Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LOOS M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 103

  • Page / 5
Export

Selection :

  • and

SATAN ALS ERSTGEBORENER GOTTES. (EIN BEITRAG ZUR ANALYSE DES BOGOMILISCHEN MYTHUS)LOOS M.BYZANT. BULG. 1969, Vol 3, PP. 23-35Article

BIOSYNTHESIS OF THE COLLAGEN LIKE C1Q MOLECULE AND ITS RECEPTOR FUNCTIONS FOR FC AND POLYANIONIC MOLECULES ON MACROPHAGESLOOS M.1983; CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY; ISSN 0070-217X; DEU; DA. 1983; VOL. 102; PP. 1-56; BIBL. 11 P.Article

DOPPELBLINDSTUDIE MIT NAB 365 UND ZWEI WEITEREN SYMPATHIKOMINETIKA ZUR UEBERPRUEFUNG VON LUNGENFUNKTIONS-UND KREISLAUF PARAMETERN SOWIE DES SCHLAFVERHALTENS = ETUDE A DOUBLE INSU AVEC LE NAB 365 ET DEUX AUTRES SYMPATHOMIMETIQUES DE L'ACTION SUR LA FONCTION PULMONAIRE SUR LES PARAMETRES DE LA CIRCULATION ET SUR LE SOMMEILLOOS M.1975; WIEN. MED. WSCHR.; OESTERR.; DA. 1975; SUPPL. 23; PP. 7-11; BIBL. 16 REF.Article

KLINISCHE BEFUNDE BEI KINDERN MIT SELEKTIVEM MANGEL AN CLQ, EINER UNTEREINHEIT DER ERSTEN KOMPLENENTKOMPONENTE = SIGNES CLINIQUES CHEZ LES ENFANTS AYANT UN DEFICIT SELECTIF DE LA FRACTION CLQ DU COMPLEMENTBERKEL AI; LOOS M.1983; MONATSSCHRIFT FUER KINDERHEILKUNDE; ISSN 0026-9298; DEU; DA. 1983; VOL. 131; NO 3; PP. 161-165; ABS. ENG; BIBL. 11 REF.Article

KILLING OF THE S AND RE FORMS OF SALMONELLA MINNESOTA VIA THE CLASSICAL PATHWAY OF COMPLEMENT ACTIVATION INGUINEA-PIG AND HUMAN SERACLAS F; LOOS M.1980; IMMUNOLOGY; GBR; DA. 1980; VOL. 40; NO 4; PP. 547-556; BIBL. 19 REF.Article

ANTIBODY-INDEPENDENT BINDING OF THE FIRST COMPONENT OF COMPLEMENT (C1) AND ITS SUBCOMPONENT C1Q TO THE S AND R FORMS OF SALMONELLA MINNESOTACLAS F; LOOS M.1981; INFECT. IMMUN.; ISSN 0019-9567; USA; DA. 1981; VOL. 31; NO 3; PP. 1138-1144; BIBL. 19 REF.Article

TRINITROPHENYLATED RED CELLS (E-TNP) AS A MODEL FOR ANTIBODY-INDEPENDENT ACTIVATION OF THE COMPLEMENT SYSTEM VIA THE CALSSICAL PATHWAY.LOOS M; THESEN R.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 1; PP. 24-28; BIBL. 22 REF.Article

Le fonctionnement à faible charge des centrales thermiques industrielles. Application du système TDC 3000 à la conduite des chaudières industrielles = Operating the industrial power plant at part load. The TDC 3000 system applied to the control of industrial boilersLOOS, M.Pétrole et techniques. 1987, Num 331, pp 52-56, issn 0152-5425Article

Courant mystique et courant hérétique dans la société byzantine in XVI. Internationaler Byzantinistenkongress, Wien 1981LOOS, M.Jahrbuch der Osterreichischen Byzantinistik Wien. 1982, Vol 32, Num 2, pp 237-246Article

MODE OF INTERACTION OF DIFFERENT POLYANIONS WITH THE FIRST (C1, C1) THE SECOND (C2) AND THE FOURTH (C4) COMPONENT OF COMPLEMENT. IV. ACTIVATION OF C1 IN SERUM BY POLYANIONS.LOOS M; BITTER SHERMANN D.1976; IMMUNOLOGY; G.B.; DA. 1976; VOL. 31; NO 6; PP. 931-934; BIBL. 11 REF.Article

INTERACTION OF THE FIRST (C1), THE SECOND (C2) AND THE FOURTH (C4) COMPONENT OF COMPLEMENT WITH DIFFERENT PREPARATIONS OF BACTERIAL LIPOPOLYSACCHARIDES AND WITH LIPID A = INTERACTION DU PREMIER (C1), DU DEUXIEME (C2) ET DU QUATRIEME (C4) COMPOSANTS DU COMPLEMENT AVEC DIFFERENTES PREPARATIONS DE LIPOPOLYOSIDES BACTERIENS ET AVEC LE LIPIDE ALOOS M; BITTER SUERMANN D; DIERICH M et al.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 112; NO 3; PP. 935-940; BIBL. 14REF.Article

THE RECONSTITUTION OF HUMAN C1, THE FIRST COMPLEMENT COMPONENT: BINDING OF C1R AND C1S TO C1Q INFLUENCES THE C1Q CONFORMATIONGOLAN MD; HITSCHOLD T; LOOS M et al.1981; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1981; VOL. 128; NO 2; PP. 281-285; BIBL. 17 REF.Article

BIOSYNTHESIS OF THE FIRST COMPONENT OF COMPLEMENT BY HUMAN AND GUINEA PIG PERITONEAL MACROPHAGES: EVIDENCE FOR AN INDEPENDENT PRODUCTION OF THE C1 SUBUNITSMULLER W; HANAUSKE ABEL H; LOOS M et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 4; PP. 1578-1584; BIBL. 49 REF.Article

REVERSIBLE INHIBITION OF C1Q RELEASE FROM GUINEA PIG MACROPHAGES BY 2,2'-DIPYRIDYL. EVIDENCE FOR A POSTTRANSLATIONAL HYDROXYLATION STEP IN THE BIOSYNTHESIS OF CLQ, A SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT (CL).MULLER W; HANAUSKE ABEL H; LOOS M et al.1978; F.E.B.S. LETTERS; NLD; DA. 1978; VOL. 90; NO 2; PP. 218-222; BIBL. 36 REF.Article

INSOLUBLE POLYANIONS AS ACTIVATORS OF BOTH PATHWAYS OF COMPLEMENT.BURGER R; BITTER SUERMANN D; LOOS M et al.1977; IMMUNOLOGY; G.B.; DA. 1977; VOL. 33; NO 6; PP. 827-837; BIBL. 1 P. 1/2Article

TREPONEMA-PALLIDUM-HAEMAGGLUTINATIONS (TPHA) - TEST BEURTEILUNG DER LEISTUNGSFAEHIGKEIT ALS LUES-SCREENING BEI BLUTSPENDEN. = TEST TPHA. EFFICACITE EN TANT QUE TEST DE DEPISTAGE DE LA SYPHILIS CHEZ DES DONNEURS DE SANGEHRKE K; BITZ H; LOOS M et al.1977; AERZTL. LAB.; DTSCH.; DA. 1977; VOL. 23; NO 10; PP. 425-430; ABS. ANGL.Article

ISOLATION AND PARTIAL CHARACTERIZATION OF A POLYSACCHARIDE IN ANT VENOM (PSEUDOMYRMEX SP.) THAT ACTIVATES THE CLASSICAL COMPLEMENT PATHWAYSCHULTZ DR; ARNOLD PI; WU MC et al.1973; MOL. IMMUNOL.; GBR; DA. 1973; VOL. 16; NO 4; PP. 253-264; BIBL. 44 REF.Article

CHIMIOTHERAPIE INTENSIVE SUIVIE D'AUTOGREFFE POUR LE TRAITEMENT DES LYMPHOMES MALINS REFRACTAIRES A LA CHIMIOTHERAPIE CLASSIQUE: REALISATION ET PROJETSSTRYCKMANS P; DEBUSSCHER L; DELFORGE A et al.1982; REV. MED. BRUX.; ISSN 0035-3639; BEL; DA. 1982; VOL. 3; NO 4; PP. 255-260; ABS. ENG; BIBL. 31 REF.Article

IMMUNOFLUORESCENCE STUDIES ON THE SUBCOMPONENTS OF THE FIRST COMPONENT OF COMPLEMENT (C1): DETECTION OF C1Q AND C1S IN DIFFERENT CELLS OF BIOPSY MATERIAL AND ON HUMAN AS WELL AS ON GUINEA PIG PERITONEAL MACROPHAGESLOOS M; STORZ R; MUELLER W et al.1981; IMMUNOBIOLOGY; DEU; DA. 1981; VOL. 158; NO 3; PP. 213-224; BIBL. 32 REF.Article

CLINICAL AND IMMUNOLOGICAL STUDIES IN A CASE OF SELECTIVE COMPLETE C1Q DEFICIENCYBERKEL AI; SANAL O; LOOS M et al.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 38; NO 1; PP. 52-63; BIBL. 2 P.Article

DETECTION OF ENDOTOXIN IN COMMERCIAL-L-ASPARAGINASE PREPARATIONS BY COMPLEMENT FIXATION AND SEPARATION BY CHROMATOGRAPHY = DETECTION D'ENDOTOXINE DANS DES PREPARATIONS COMMERCIALES DE L'ASPARAGINASE PAR FIXATION DU COMPLEMENT ET SEPARATION PAR CHROMATOGRAPHIELOOS M; VADLAMUDI S; MELTZER M et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 11; PP. 2292-2296; BIBL. 12REF.Serial Issue

DIFFERENTIATION OF HEMOLYTICALLY ACTIVE FLUID-PHASE AND CELL-BOUND HUMAN C19 BY AN ANT VENOM-DERIVED POLYSACCHARIDESCHULTZ DR; LOOS M; BUB F et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 3; PP. 1251-1257; BIBL. 31 REF.Article

ULTRACENTRIFUGATION STUDIES ON THE NATIVE FORM OF THE FIRST COMPONENT OF HUMAN COMPLEMENT (C1)LOOS M; HILL HU; WELLEK B et al.1976; F.E.B.S. LETTERS; NETHERL.; DA. 1976; VOL. 64; NO 2; PP. 341-345; BIBL. 22 REF.Article

IMMUNOCHEMICAL AND FUNCTIONAL ANALYSES OF A COMPLETE C1Q DEFICIENCY IN MAN: EVIDENCE THAT C1R AND C1S ARE IN THE NATIVE FORM, AND THAT THEY REASSOCIATE WITH PURIFIED C1Q TO FORM MACROMOLECULAR C1LOOS M; LAURELL AB; SJOHOLM AG et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 1; PP. 59-63; BIBL. 29 REF.Article

INTERACTIONS BETWEEN MYCOPLASMA PNEUMONIAE AND THE FIRST COMPONENT OF COMPLEMENT.BREDT W; WELLEK B; BRUNNER H et al.1977; INFECT. AND IMMUN.; U.S.A.; DA. 1977; VOL. 15; NO 1; PP. 7-12; BIBL. 16 REF.Article

  • Page / 5